952 related articles for article (PubMed ID: 20158954)
1. Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment.
Fayed N; Dávila J; Oliveros A; Medrano J; Castillo J
Neurol Res; 2010 Mar; 32(2):157-65. PubMed ID: 20158954
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
3. Multimodal imaging in diagnosis of Alzheimer's disease and amnestic mild cognitive impairment: value of magnetic resonance spectroscopy, perfusion, and diffusion tensor imaging of the posterior cingulate region.
Zimny A; Szewczyk P; Trypka E; Wojtynska R; Noga L; Leszek J; Sasiadek M
J Alzheimers Dis; 2011; 27(3):591-601. PubMed ID: 21841260
[TBL] [Abstract][Full Text] [Related]
4. Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable dementia.
Fayed N; Dávila J; Oliveros A; Castillo J; Medrano JJ
Acad Radiol; 2008 Sep; 15(9):1089-98. PubMed ID: 18692749
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
[TBL] [Abstract][Full Text] [Related]
6. [Cognitive impairment: classification by proton magnetic resonance spectroscopy and the contributions of conventional magnetic resonance imaging].
Martínez-Bisbal MC; Arana E; Martí-Bonmatí L; Martínez-Granados B; Celda B
Radiologia; 2006; 48(5):301-7. PubMed ID: 17168239
[TBL] [Abstract][Full Text] [Related]
7. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
Wang Z; Zhao C; Yu L; Zhou W; Li K
Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
[TBL] [Abstract][Full Text] [Related]
8. Diffusion tensor imaging correlates with proton magnetic resonance spectroscopy in posterior cingulate region of patients with Alzheimer's disease.
Ding B; Chen KM; Ling HW; Zhang H; Chai WM; Li X; Wang T
Dement Geriatr Cogn Disord; 2008; 25(3):218-25. PubMed ID: 18219201
[TBL] [Abstract][Full Text] [Related]
9. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy.
Modrego PJ; Fayed N; Pina MA
Am J Psychiatry; 2005 Apr; 162(4):667-75. PubMed ID: 15800137
[TBL] [Abstract][Full Text] [Related]
10. The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study.
Waldman AD; Rai GS
Neuroradiology; 2003 Aug; 45(8):507-12. PubMed ID: 12879326
[TBL] [Abstract][Full Text] [Related]
11. Differences in brain metabolism associated with agitation and depression in Alzheimer's disease.
Tsai CF; Hung CW; Lirng JF; Wang SJ; Fuh JL
East Asian Arch Psychiatry; 2013 Sep; 23(3):86-90. PubMed ID: 24088401
[TBL] [Abstract][Full Text] [Related]
12. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
13. Congenital muscular dystrophy with merosin deficiency: 1H MR spectroscopy and diffusion-weighted MR imaging.
Leite CC; Reed UC; Otaduy MC; Lacerda MT; Costa MO; Ferreira LG; Carvalho MS; Resende MB; Marie SK; Cerri GG
Radiology; 2005 Apr; 235(1):190-6. PubMed ID: 15703311
[TBL] [Abstract][Full Text] [Related]
14. 1H-proton magnetic resonance spectroscopy differentiates dementia with Lewy bodies from Alzheimer's disease.
Zhong X; Shi H; Shen Z; Hou L; Luo X; Chen X; Liu S; Zhang Y; Zheng D; Tan Y; Huang G; Fang Y; Zhang H; Mu N; Chen J; Wu R; Ning Y
J Alzheimers Dis; 2014; 40(4):953-66. PubMed ID: 24531156
[TBL] [Abstract][Full Text] [Related]
15. In vivo evaluation of brain damage in the course of systemic lupus erythematosus using magnetic resonance spectroscopy, perfusion-weighted and diffusion-tensor imaging.
Zimny A; Szmyrka-Kaczmarek M; Szewczyk P; Bladowska J; Pokryszko-Dragan A; Gruszka E; Wiland P; Sasiadek M
Lupus; 2014; 23(1):10-9. PubMed ID: 24192079
[TBL] [Abstract][Full Text] [Related]
16. Metabolite investigation in both anterior and posterior cingulate gyri in Alzheimer's disease spectrum using 3-tesla MR spectroscopy.
Lim TS; Hong YH; Lee HY; Choi JY; Kim HS; Moon SY
Dement Geriatr Cogn Disord; 2012; 33(2-3):149-55. PubMed ID: 22722669
[TBL] [Abstract][Full Text] [Related]
17. [Dementias: diagnostic contribution of imaging and proton magnetic resonance spectroscopy].
Arana E; Martínez-Granados B; Marti-Bonmati L; Martínez-Bisbal MC; Gil A; Blasco C; Celda B
Neurologia; 2007 Jun; 22(5):267-74. PubMed ID: 17508300
[TBL] [Abstract][Full Text] [Related]
18. [Cerebral metabolism in patients with cognitive disorders: a combined MRS and PET study].
Khomenko YG; Kataeva GV; Bogdan AA; Chernysheva EM; Susin DS
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(1):51-58. PubMed ID: 30778031
[TBL] [Abstract][Full Text] [Related]
19. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
Almuqbel M; Melzer TR; Myall DJ; MacAskill MR; Pitcher TL; Livingston L; Wood KL; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26627939
[TBL] [Abstract][Full Text] [Related]
20. Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy.
Modrego PJ; Pina MA; Fayed N; Díaz M
CNS Drugs; 2006; 20(10):867-77. PubMed ID: 16999455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
